The Globe and Mail reports in its Friday, Aug. 4, edition that Raymond James analyst Brian MacArthur is sticking with his "outperform" call for Cameco. The Globe's David Leeder writes that Mr. MacArthur boosted his share target to $52 from $50. Analysts on average target the shares at $48.94. Mr. MacArthur says in note: "We believe Cameco provides investors with lower-risk exposure to the uranium market given its diversification of uranium sources. These sources are supported by a portfolio of long-term contracts that provide some downside protection in periods of depressed spot uranium prices, while maintaining optionality to higher uranium prices. In addition, the company has multiple operations curtailed that can be brought back should uranium prices increase. Although the 2021 tax court decision applies only to the 2003, 2005, and 2006 tax years, we view it as a positive for Cameco given we believe it will be relevant in determining the outcome for other years and reduces risk related to the CRA dispute." The Globe reported on Jan. 12 and May 2 that Mr. MacArthur rated Cameco "outperform" when it could be had for $34.24 and $36.69. In the May 12 item, Mr. MacArthur called Cameco a "lower risk" play.